Home / Medicine / Helicid

Helicid

Countries
Bulgaria Czech Republic Georgia Hungary Poland Romania Russia Slovakia
Diseases
Peptic Ulcer Reflux Reflux Esophagitis Zollinger-Ellison Syndrome Esophagitis Duodenal Ulcer Heartburn Esophageal Reflux Helicobacter Pylori Stomach Ulcer
Ingredients
Omeprazole
Drug Actions
Antiulcer Drugs for acid related disorders Antacid Inhibiting h +, k + -atp-ase Proton pump inhibitor
How does this drug class actually work?
Read the plain-language explainer in Pharmacology Academy (Proton pump inhibitors) →

Drugs with the same active ingredients

Acimed Aziatop Buscasan Danlox Danlox rapido Dioxaflex protect Faboacid plus Fabrazol Fada omeprazol Fendiprazol Gastec Gastrotem Klomeprax Lafeprazol Losec Lyncis Oblisec Omefar Omefort Omeprasec

Incompatibilities

Not applicable.

Preclinical safety data

Gastric ECL-cell hyperplasia and carcinoids have been observed in life-long studies in rats treated with Helicid. These changes are the result of sustained hypergastrinaemia secondary to acid inhibition. Similar findings have been made after treatment with H2-receptor antagonists, proton pump inhibitors and after partial fundectomy. Thus, these changes are not from a direct effect of any individual active substance.

Special precautions for disposal and other handling

No special requirements for disposal.

Available in 8 countries